Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Theratechnologies Inc T.TH

Alternate Symbol(s):  THTX

Theratechnologies Inc. is a Canada-based clinical-stage biopharmaceutical company. The Company is focused on the development and commercialization of therapies addressing unmet medical needs. It markets prescription products for people with human immunodeficiency viruses (HIV) in the United States. The Company's research pipeline focuses on specialized therapies addressing unmet medical needs in HIV, nonalcoholic steatohepatitis (NASH) and oncology. Its medicines include Trogarzo and EGRIFTA SV (tesamorelin for injection). Trogarzo (ibalizumab-uiyk) injection is a long-acting monoclonal antibody which binds to domain 2 of the CD4 T cell receptors. EGRIFTA SV (tesamorelin for injection) is approved in the United States for the reduction of excess abdominal fat in people with HIV who have lipodystrophy. Its portfolio includes Phase I clinical trial of sudocetaxel zendusortide (TH1902), a novel peptide-drug conjugate (PDC), in patients with advanced ovarian cancer.


TSX:TH - Post by User

Comment by Lee430on Feb 28, 2024 12:07pm
101 Views
Post# 35904067

RE:What happened to that guy

RE:What happened to that guyIt seems that we have returned to the same collective opinion of Thera’s BOD & PL since this time last year before the AGM, unfortunately for us this time around Thera made sure we could not threaten there jobs with the need for change by punishing us with HEAVY & CHEAP dilution…At one point I held almost 1% of Thera and was keeping the faith, but now I am so diluted that my voice is just a small chirp and have little recourse to help right the ship….Pinning my hopes on a positive surprise for TH1902 or a large player stepping in that salvages some of our investments…..We know how were voting at this year’s AGM so let’s hope the heavyweights also decide to join us for some positive change this year.

palinc2000 wrote: This is taken from the transcript of Paul s first CC on April 14 th 2020,,,,,,ALL looked exactly what we needed BUT he never walked that talk,,,,

This said let's talk about my 60 or 90 day plan. During my career, I must have transitioned to new roles over 15 times. Every time I go at it in a very simple, but systematic way. This time will be no different, as I will start by assessing capabilities within the company.

I will then review our business model and pin down the levers of success and the investment required to fully activate them. Once everyone is on board with what the right plan is, then we will focus on the execution. And I will hold people accountable for doing what needs to be done. As previously said, this is a simple way to dive and assess the situation, but it is the best way to share objectives and get colleagues to work as a cohesive team.



<< Previous
Bullboard Posts
Next >>